MTOR and Alzheimer disease: Animal studies suggest that mTOR inhibitor drugs, such as rapamycin, may aid to lower the AD progression or ameliorate cognitive impairments of AD12, 13; however, based on the data retrieved from clinicaltrial.gov, there is no terminated clinical trial on elucidating the effects of rapamycin on delaying the progression of AD to date.